Joel L Pomerantz

11PUBLICATIONS
19CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8+ T cell activation via the CARD11 signalosome.

Nicole M Carter, Wihib D Hankore, Yong-Kang Yang

|Nov 10, 2023
SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation.

Rachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel

|Aug 03, 2021
Pathway-Specific Defects in T, B, and NK Cells and Age-Dependent Development of High IgE in Mice Heterozygous for a CADINS-Associated Dominant Negative CARD11 Allele.

Shelby M Hutcherson, Jacquelyn R Bedsaul, Joel L Pomerantz

|Feb 24, 2021
Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools.

Waipan Chan, Rachel A Gottschalk, Yikun Yao

|Jun 24, 2020
HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo.

Andrew Timmons, Emily Fray, Mithra Kumar

|Aug 09, 2019
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling.

Zhaoquan Wang, Shelby M Hutcherson, Chao Yang

Pageof 2